February 2024
1. SCHULTE C, Pieper L, Frye M, Waldeyer C, et al
   Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease.
   J Thromb Haemost. 2024;22:553-557.
   

   >> Share

   
   November 2023
2. ALENAZY FO, Harbi MH, Kavanagh DP, Price J, et al
   Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.
   J Thromb Haemost. 2023;21:3236-3251.
   

   >> Share

   
   September 2023
3. YUAN L, Han J, van der Velden AIM, Vink H, et al
   Sex-specific association between microvascular health and coagulation parameters: the Netherlands Epidemiology of Obesity study.
   J Thromb Haemost. 2023;21:2585-2595.
   

   >> Share

   
   August 2023
4. KANAGARATNAM P, Francis DP, Chamie D, Coyle C, et al
   A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial.
   J Thromb Haemost. 2023;21:2213-2222.
   

   >> Share

   
   March 2023
5. SWAN D, Connors JM, Thachil J
   Dilemmas in hematology: consults in patients with arterial thrombosis.
   J Thromb Haemost. 2023;21:421-432.
   

   >> Share

   
   July 2022
6. SEJRUP JK, Tondel BG, Morelli VM, Lochen ML, et al
   Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromso Study.
   J Thromb Haemost. 2022 Jul 11. doi: 10.1111/jth.15812.
   

   >> Share

   
   November 2021
7. FOLSOM AR, de Vries PS, Cushman M
   No prospective association of a polygenic risk score for coronary artery disease with venous thromboembolism incidence.
   J Thromb Haemost. 2021;19:2841-2844.
   

   >> Share

   
   
8. CHEN H, Shen M, Niu R, Mu X, et al
   Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case-control study.
   J Thromb Haemost. 2021;19:2781-2790.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share